PSMB5 and osteosarcoma: A recent study stated that upregulation of the PSMB5 gene in osteosarcoma cell line (~295 nTPM) with an upregulated PSMB5 gene correlation was observed with the increase in the resistance of these cells to the bortezomib treatment [29].